Anastasia Shchendrygina, MD, PhD, discusses her recent study evaluating colchicine’s effects on major biomarkers of HFpEF and its pathophysiology.
Anastasia Shchendrygina, MD, PhD
Advertisement
Anastasia Shchendrygina, MD, PhD, is an associate professor at I.M. Sechenov First Moscow State Medical University.
Articles by Anastasia Shchendrygina, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Tezepelumab Meets Co-Primary End Points in Phase 3 CROSSING Trial in EoE
2
Tenapanor Linked to Lower IBS-C Care Use, With Kyle Staller, MD, MPH
3
Ratio of sTTR and NT-proBNP Change May Predict Treatment Results in ATTR-CM
4
52-Week Litifilimab Data in Cutaneous Lupus Erythematosus
5